Novo Nordisk (NVO)
(Delayed Data from NYSE)
$131.89 USD
-1.15 (-0.86%)
Updated May 17, 2024 04:00 PM ET
After-Market: $131.88 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | 0.83 |
EPS Last Quarter | 0.83 |
Last EPS Surprise | 7.79% |
ABR | 1.54 |
Earnings ESP
|
0.40% |
---|---|
Current Year | 3.43 |
Next Year | 4.32 |
EPS (TTM) | 2.90 |
P/E (F1) | 38.47 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.95B | 11.27B | 42.42B | 52.35B |
# of Estimates | 1 | 1 | 2 | 3 |
High Estimate | 9.95B | 11.27B | 43.40B | 52.94B |
Low Estimate | 9.95B | 11.27B | 41.45B | 51.65B |
Year ago Sales | 7.93B | 8.58B | 33.71B | 42.42B |
Year over Year Growth Est. | 25.39% | 31.40% | 25.85% | 23.40% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.83 | 0.98 | 3.43 | 4.32 |
# of Estimates | 3 | 1 | 5 | 4 |
Most Recent Consensus | NA | NA | 3.20 | NA |
High Estimate | 0.84 | 0.98 | 3.60 | 4.72 |
Low Estimate | 0.82 | 0.98 | 3.20 | 3.76 |
Year ago EPS | 0.63 | 0.73 | 2.70 | 3.43 |
Year over Year Growth Est. | 31.75% | 34.25% | 27.04% | 26.08% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 1 |
Up Last 30 Days | 0 | 0 | 4 | 4 |
Up Last 60 Days | 0 | 0 | 3 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.83 | 0.98 | 3.43 | 4.32 |
7 Days Ago | 0.82 | 0.98 | 3.37 | 4.23 |
30 Days Ago | 0.82 | 0.98 | 3.32 | 4.09 |
60 Days Ago | NA | NA | 3.36 | 4.15 |
90 Days Ago | NA | NA | 3.33 | 4.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.83 | 0.98 | 3.43 | 4.32 |
Zacks Consensus Estimate | 0.83 | 0.98 | 3.43 | 4.32 |
Earnings ESP | 0.40% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.83 | 0.71 | 0.73 | 0.63 | NA |
Estimate | 0.77 | 0.66 | 0.69 | 0.67 | NA |
Difference | 0.06 | 0.05 | 0.04 | -0.04 | 0.03 |
Surprise | 7.79% | 7.58% | 5.80% | -5.97% | 3.80% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more